Found: 18
Select item for more details and to access through your institution.
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 2, p. 159, doi. 10.3390/ph14020159
- By:
- Publication type:
- Article
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14197, doi. 10.3390/ijms232214197
- By:
- Publication type:
- Article
Moving beyond PARP Inhibition: Current State and Future Perspectives in Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 15, p. 7884, doi. 10.3390/ijms22157884
- By:
- Publication type:
- Article
AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5515, doi. 10.3390/ijms22115515
- By:
- Publication type:
- Article
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 2, p. 421, doi. 10.1007/s10549-020-05856-3
- By:
- Publication type:
- Article
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231204857
- By:
- Publication type:
- Article
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231161412
- By:
- Publication type:
- Article
Author Correction to: Advances in anti-BRAF therapies for lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Advances in anti-BRAF therapies for lung cancer.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 3, p. 879, doi. 10.1007/s10637-021-01068-8
- By:
- Publication type:
- Article
Cancer management during the COVID-19 world pandemic.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3427, doi. 10.1007/s00262-023-03524-1
- By:
- Publication type:
- Article
Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 703, doi. 10.3390/cancers15030703
- By:
- Publication type:
- Article
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 96, doi. 10.3390/cancers15010096
- By:
- Publication type:
- Article
Early Changes of the Standardized Uptake Values (SUV max) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3314, doi. 10.3390/cancers12113314
- By:
- Publication type:
- Article
Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.686776
- By:
- Publication type:
- Article
An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00534-1
- By:
- Publication type:
- Article
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1083297
- By:
- Publication type:
- Article
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.882896
- By:
- Publication type:
- Article